Cellectar Biosciences, Inc. (CLRB) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$3.38M2011: -$5.97M2016: -$8.28M2017: -$11.02M2018: -$11.44M2019: -$11.69M2020: -$13.93M2021: -$22.57M2022: -$25.22M2023: -$32.38M2024: -$47.58M2025: -$23.12M-$23.12M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$23.12M+51.4%
2024-$47.58M-47.0%
2023-$32.38M-28.4%
2022-$25.22M-11.8%
2021-$22.57M-62.0%
2020-$13.93M-19.1%
2019-$11.69M-2.2%
2018-$11.44M-3.8%
2017-$11.02M-33.1%
2016-$8.28M
2011-$5.97M-76.5%
2010-$3.38M